Pfizer Lookout For A Partner For Drug Manufacturing
p { text-align:justify; }
p { text-align:justify; }
INTRODUCTION There are around 800 producers of pharmaceutical goods and devices in India, and the country's market is the fourth largest in Asia. The current period can be described as transitory since many regulatory changes have yet to take effect,…
Introduction Patents and public health is the most relevant topic of discussion when the whole world is fighting against the global pandemic, Covid-19. It is no doubt that granting patent protection to a drug is important and serves many purposes,…
There is a constant conundrum between Intellectual Property and Human Rights in today’s day and age. There has been an emergence of International Human Rights obligations post World War II. A plethora of International Organizations like the WHO (public health),…
Introduction The pharmaceutical industry is one of the most potential industry which has huge profit margins. Extensive growth and knowledge are required with frequent changes for better technology and results. Starting from early to the final stage there are gigantic…
It is not new that the Supreme Court had cautiously laid down the seven principles for determining confusion or deceptiveness in pharmaceutical products. The landmark case of Cadilla held that medicines are boon but if given wrongly it can have…
IIPRD, along with Khurana & Khurana, Advocates and IP Attorneys (K&K) and its eminent foreign associates, conducted Third edition of International Patent Drafting Competition (IPDC). IPDC was designed with an objective to test acumen and skill set of various practitioners…
Reportedly, on an appeal filed by Cipla pertaining to COPD drug INDAFLO, the Delhi High court division bench maintained the interim injunction imposed by single judge against Cipla. As per the order, Cipla has now been restrained from, inter alia,…
We have been receiving requests from our Pharma clients/readers of the blog for the analysis of the decision/ facts that led to rejection of Lumacaftor (Polymorph) patent application in India since last year. Here is our take: Details of the…
UCB Pharma, a Belgian pharmaceutical company, announced on 14th August 2016 that the U.S. District Court for the District of Delaware confirmed the validity of its U.S. reissued patent RE38551 related to anti-epileptic drug Vimpat® (lacosamide). The patent challenge was…